These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
223 related articles for article (PubMed ID: 7246011)
1. [Clinical value of serum thyroglobulin and 131I-whole body retention measurements in the diagnosis of metastases from differentiated thyroid carcinoma (author's transl)]. Weissel M; Bergmann H; Höfer R Acta Med Austriaca; 1980; 7(4-5):114-9. PubMed ID: 7246011 [No Abstract] [Full Text] [Related]
2. Complementary role of whole body scan and serum thyroglobulin determination in the follow-up of differentiated thyroid carcinoma. Ronga G; Fiorentino A; Fragasso G; Fringuelli FM; Todino V Ital J Surg Sci; 1986; 16(1):11-5. PubMed ID: 3087907 [TBL] [Abstract][Full Text] [Related]
3. Serum thyroglobulin concentrations and 131I whole body scans in the diagnosis of metastases from differentiated thyroid carcinoma (after thyroidectomy). Pacini F; Pinchera A; Giani C; Grasso L; Baschieri L Clin Endocrinol (Oxf); 1980 Jul; 13(1):107-10. PubMed ID: 7438460 [TBL] [Abstract][Full Text] [Related]
4. Serum thyroglobulin and iodine-131 whole-body scan in the diagnosis and assessment of treatment for metastatic differentiated thyroid carcinoma. Lubin E; Mechlis-Frish S; Zatz S; Shimoni A; Segal K; Avraham A; Levy R; Feinmesser R J Nucl Med; 1994 Feb; 35(2):257-62. PubMed ID: 8294995 [TBL] [Abstract][Full Text] [Related]
5. Can iodine-131 whole-body scan be replaced by thyroglobulin measurement in the post-surgical follow-up of differentiated thyroid carcinoma? Ronga G; Fiorentino A; Paserio E; Signore A; Todino V; Tummarello MA; Filesi M; Baschieri I J Nucl Med; 1990 Nov; 31(11):1766-71. PubMed ID: 2121913 [TBL] [Abstract][Full Text] [Related]
6. Thallium-201 scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum thyroglobulin determinations. Ramanna L; Waxman A; Braunstein G J Nucl Med; 1991 Mar; 32(3):441-6. PubMed ID: 2005453 [TBL] [Abstract][Full Text] [Related]
7. [Metastatic differentiated thyroid cancer. Diagnostic accuracy of thyroglobulin-RIA in comparison with 131I-whole body scintigraphy]. Reiners C; Reimann J; Schäffer R; Baum K; Becker W; Eilles C; Gerhards W; Schick F; Spiegel W; Wiedemann W Rofo; 1984 Sep; 141(3):306-13. PubMed ID: 6435198 [TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy. Moser E; Fritsch S; Braun S Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222 [TBL] [Abstract][Full Text] [Related]
9. Thyroglobulin radioimmunoassay and 131I scintigraphy in patients with differentiated thyroid carcinoma. Lindegaard MW; Paus E; Høie J; Kullman G; Stenwig AE Acta Chir Scand; 1988 Feb; 154(2):141-5. PubMed ID: 3354295 [TBL] [Abstract][Full Text] [Related]
10. [Use of serum thyroglobulin determination in the follow-up of differentiated carcinomas of the thyroid]. Secades Ariz I; Pérez Piqueras JL; Labanda Tejedor P; Cordero Peinado J An Med Interna; 1988 Sep; 5(9):439-43. PubMed ID: 2856622 [No Abstract] [Full Text] [Related]
11. [The correlation between serum thyroglobulin and iodine-131 scanning in detecting metastases in patients with a differentiated thyroid carcinoma]. Abduluakhab M; Gavrilov M; Mladenov B Khirurgiia (Sofiia); 1997; 50(4):33-6. PubMed ID: 9739856 [TBL] [Abstract][Full Text] [Related]
12. [Serum thyroglobulin in the diagnosis of metastases of differentiated thyroid cancer. Effect of suppressive thyroid hormone substitution on the diagnostic accuracy of thyroglobulin values]. Müller-Gärtner HW; Schneider C; Tempel MT Nuklearmedizin; 1986 Oct; 25(5):194-200. PubMed ID: 3797259 [TBL] [Abstract][Full Text] [Related]
13. [Significance of thyroglobulin as a tumor marker in the serum of patients with differentiated thyroid carcinoma: longitudinal and cross-sectional studies (author's transl)]. Schatz H; Grebe S; Mäser E; Teuber J; Horn W; Schröder O; Schatz C Klin Wochenschr; 1982 May; 60(9):457-64. PubMed ID: 7045510 [TBL] [Abstract][Full Text] [Related]
14. Role of thallium-201 total-body scintigraphy in follow-up of thyroid carcinoma. Hoefnagel CA; Delprat CC; Marcuse HR; de Vijlder JJ J Nucl Med; 1986 Dec; 27(12):1854-7. PubMed ID: 3097277 [TBL] [Abstract][Full Text] [Related]
15. Thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma in children. Antonelli A; Miccoli P; Fallahi P; Ferrari SM; Grosso M; Boni G; Berti P Surgery; 2006 Dec; 140(6):1035-41; discussion 1041-2. PubMed ID: 17188154 [No Abstract] [Full Text] [Related]
16. [Postoperative follow-up in differentiated carcinoma of the thyroid gland]. Pandolfi C Minerva Med; 1986 Jun; 77(27):1317-9. PubMed ID: 3725155 [TBL] [Abstract][Full Text] [Related]
17. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level. Miller JH; Marcus CS Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613 [TBL] [Abstract][Full Text] [Related]
18. [Thyroglobulin, 131I-whole body scintigraphy and risk factors in the follow-up of differentiated thyroid cancer]. Berding G; Hüfner M; Georgi P Nuklearmedizin; 1992 Feb; 31(1):32-7. PubMed ID: 1561118 [TBL] [Abstract][Full Text] [Related]
19. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone. Rudavsky AZ; Freeman LM J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223 [No Abstract] [Full Text] [Related]
20. A comparison of serum thyroglobulin measurements and whole body 131I scanning in the management of treated differentiated thyroid carcinoma. Galligan JP; Winship J; van Doorn T; Mortimer RH Aust N Z J Med; 1982 Aug; 12(4):248-54. PubMed ID: 6814409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]